We are aware that India has authorized two vaccines against coronavirus—Covaxin developed by Hyderabad-based Bharat Biotech and Covishield produced by the Serum Institute of India — for emergency use in the country.
The Bharat Biotech on Wednesday said that its Covaxin vaccine was 81 percent efficient in preventing coronavirus after the third round of clinical trials. The vaccine has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology.
The trials involved 25,800 participants and were conducted in partnership with ICMR. This was the largest ever trial conducted in the country.
“The Phase 3 study enrolled 25,800 participants between 18-98 years of age, including 2,433 over the age of 60 and 4,500 with comorbidities,” the company said in a statement.
Earlier this week, Indian Prime Minister Narendra Modi, Union Home Minister Amit Shah and other Ministers from the cabinet was vaccinated with the first dose of Covaxin.
Janasena chief Pawan Kalyan is leading his most important election campaign till date as he…
RK Sagar, known for “Mogali Rekulu,” is back in movies with a new film called…
“Odela 2” movie produced by Madhu Creations and Sampath Nandi Teamworks is directed by Ashok…
Telugu Desam Party fans, over the years have been owning Jr NTR as their own.…
Andhra Pradesh's election process hit a new phase after the completion of the nomination filing…
Vijay Deverakonda and Parasuram came back together for Family Star after having delivered Geetha Govindam…